Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Isotechnika Pharma Inc IPHAF



GREY:IPHAF - Post by User

Comment by labumbaon Mar 18, 2010 4:14pm
367 Views
Post# 16900041

RE: RE: RE: what we need is...

RE: RE: RE: what we need is...Unlikey they are looking for partnership for psoriasis indication at present as they are in a process of NDP for psoriasis ( Canada ).....unless they need a phase3 trial in the states ( do they need one ? a question I have asked before ). I think they prefer a partner to develop both transplant and psoriasis indications together including other  transplant indications.....the " modifying " drug treatment for RA indication may be  the next trial study too

bottom line..get the drug on the market to validate its value and the rest like partnership, takeover, etc will follow
<< Previous
Bullboard Posts
Next >>